New skin cream for mild to moderate plaque psoriasis
Treatments studied
Part of Skin clinical trials.
This study tests a new topical cream for treating mild to moderate plaque psoriasis. It aims to see if the cream is safe and effective for reducing psoriasis symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have mild or moderate plaque psoriasis, confirmed by a doctor.
- You have not used any psoriasis treatments (creams, light therapy, or pills) in the last 3 months.
- You are not pregnant or breastfeeding.
- You do not have other skin conditions like eczema, lichen planus, or lupus.
- You are not allergic to topical treatments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new oral medication, CS32582, for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing skin symptoms like redness, thickness, and scaling.
This study tests an oral medication (HSK47388) as a treatment for moderate-to-severe plaque psoriasis, the most common type. It may help reduce symptoms like red, scaly patches and improve quality of life.
This study tests whether adding metformin (a diabetes medicine) to secukinumab (a biologic injection) works better for people with moderate-to-severe plaque psoriasis who are overweight or obese. It might help control psoriasis and reduce inflammation.
This study tests whether a cream containing metformin (a diabetes drug) can help treat mild plaque psoriasis when applied to the skin. It aims to see if this topical cream reduces psoriasis symptoms safely.
This study tests an experimental oral tablet (CMS-D001) to see if it can safely and effectively reduce the severity of moderate to severe plaque psoriasis. It may be an easier treatment option compared to injections or light therapy.
This trial tests a new cream form of apremilast, a medicine usually taken as a pill, for people with plaque psoriasis covering less than 10% of their body. The goal is to see if the cream is safe and effective in reducing psoriasis symptoms.
Hear when a new Plaque Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.